Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots.

Chusyd DE, Wang D, Huffman DM, Nagy TR. · 2016

Read Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots. by Chusyd DE, Wang D, Huffman DM, Nagy TR. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4835715.txt.

Introduction

Daniella E. Chusyd, Donghai Wang, Derek M. Huffman, and Tim R. Nagy published a review in Frontiers in Nutrition in 2016 on white fat in rodents and humans. Much obesity research uses rats and mice, yet the review asks how well rodent fat pads match human fat depots. It compares the two across growth, body placement, sex differences, weight loss, hormone signals, and aging.

Similar traits exist, but the review finds clear gaps in where fat sits and how it acts. Those gaps can mislead work that moves results from rodents to people. The authors call for more direct tests of matched depots, such as belly fat around the gut, before rodent findings guide human care.

Catalog record

CREATORChusyd DE, Wang D, Huffman DM, Nagy TR.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4835715

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots By Daniella E Chusyd, Donghai Wang, Derek M Huffman, Tim R Nagy Published in: Frontiers in Nutrition DOI: 10.3389/fnut.2016.00010 ABSTRACT Abstract The objective of this review was to compare and contrast the physiological and metabolic profiles of rodent white adipose fat pads with white adipose fat depots in humans. Human fat distribution and its metabolic consequences have received extensive attention, but much of what has been tested in translational research has relied heavily on rodents. Unfortunately, the validity of using rodent fat pads as a model of human adiposity has received less attention. There is a surprisingly lack of studies demonstrating an analogous relationship between rodent and human adiposity on obesity-related comorbidities. Therefore, we aimed to compare known similarities and disparities in terms of white adipose tissue (WAT) development and distribution, sexual dimorphism, weight loss, adipokine secretion, and aging. While the literature supports the notion that many similarities exist between rodents and humans, notable differences emerge related to fat deposition and function of WAT. Thus, further research is warranted to more carefully define the strengths and limitations of rodent WAT as a model for humans, with a particular emphasis on comparable fat depots, such as mesenteric fat. Keywords: rodents, humans, obesity, fat pads, fat depot, fat distribution INTRODUCTION Obesity has largely been defined by a body mass index (BMI) >30 kg/m2, or better still, a body fat percentage >25% in males and >35% in females (1). However, from a physiological standpoint, evidence indicates that body fat distribution, irrespective of BMI and/or body fat percentage, most strongly predicts risk of obesity-related diseases and complications (2). Risk can further be stratified by fat distribution, as individuals with a higher waist-to-hip ratio suffer disproportionately from obesity-related metabolic dysfunction (3). Indeed, individuals with gynoid obesity, characterized by subcutaneous fat in the gluteofemoral region, have minimal risk of developing metabolic dysfunction (3, 4); whereas individuals with the so-called android obesity, which is characterized by visceral fat accretion, suffer a greater risk of metabolic dysfunction (4, 5). The metabolic consequences of body fat and its distribution have received extensive attention in the literature. As rodents are by far the most commonly used pre-clinical model of human obesity (6–9), further validation of important commonalities and differences between rodent and humans are needed. Specifically, investigators should seriously consider to what extent their experimental approach and findings are translational. For instance, rodent adipose tissue deposition is strikingly dissimilar to humans, and adipocytes in these depots display metabolic heterogeneity and are intrinsically different within a species. As such, further research needs to focus on how specific rodent fat pads correspond, if at all, with fat depots in humans. To our knowledge, only two studies have compared gene expression in mouse fat pads to gene expression in analogous human fat depots (10, 11). Thus, given the general lack of information or discussion on this highly relevant topic, a systemic review of the literature in our view, is warranted. FAT DEPOTS VERSUS FAT PADS: ANATOMICAL CONSIDERATIONS There are three main regional human anatomical fat depots: intra-abdominal, upper-body/abdominal subcutaneous, and lower body subcutaneous (Figure 1A) (12). Intra-abdominal refers to visceral adipose tissue (VAT), which surrounds the inner organs (13). VAT can further be divided into omental, mesenteric, retroperitoneal, gonadal, and pericardial. The upper-body subcutaneous adipose tissue (SAT) can be categorized depending on if it is situated superficial or deep to the fascia superficialis. The adipose tissue below the fascia is the deep subcutaneous adipose tissue (DSAT) compartment, whereas adipose tissue located superficially to this fascia is the superficial subcutaneous adipose tissue (SSAT) compartment (14, 15). Though SAT is distributed throughout the human body, the main depots are in the abdomen, buttocks, and thighs (16). The buttocks and thighs make up the lower body SAT and are termed the gluteofemoral depot (12, 13). [Figure: (A) Distribution of fat depots in the human. The white adipose tissue (WAT) is found in subcutaneous adipose tissue (SAT) abdominally (a), gluteofemorally (g), and intramuscularly (h). WAT is also found in the visceral adipose tissue (VAT). The visceral depots are omental (b), mesenteric (c), retroperitoneal (d), gonadal (e), and pericardial (f). Brown adipose tissue is found supraclavicularly (i) and in the subscapular region (j). (B) Those fat depots linked to increased risk of developing obesity-related morbidities and mortality are colored in red (13).] Like humans, adipose tissue in rodents is a multi-depot organ (Figure 2), but unlike humans, which have two main subcutaneous depots located in the abdominal and gluteofemoral region, rodents have two main subcutaneous pads located anteriorly and posteriorly. The anterior pad is located between the scapulae, descending from the neck to the axillae (17), while, the posterior pad, or inguinal fat pad, spreads from the dorsolumbar region to the gluteal region. The inguinal fat pad is comparable in terms of location to the large gluteofemoral subcutaneous depot in humans. Additionally, rodent SAT is separated from dermal adipose tissue by a smooth muscle layer, whereas, in humans, the SAT is continuous with dermal adipose tissue (17). Furthermore, there has been no evidence to our knowledge of multiple subcutaneous layers in rodents, such as is the case in humans. [Figure: Distribution of fat pads in the mouse. The fat is composed of two subcutaneous pads and several visceral pads. The main white adipose tissue (WAT) pads are the inguinal and epididymal, with the latter being the most frequent dissected pad. Brown adipose tissue (BAT) is distributed throughout the fat pads with the main BAT depot in the interscapular region (18).] Rodents harbor visceral fat pads in the perigonadal region, known as epididymal in males and periovarian in females, as well as retroperitoneal fat pads located on the kidneys, and the mesenteric fat pad located alongside the intestinal tract. The mesenteric fat pad is widely touted as the most analogous to human intra-abdominal adipose tissue both in its location and biology, because it has access to the portal vein. However, this depot is not well studied in rodents due to limitations in its surgical manipulation and separation from contaminating vessels. The perigonadal fat pads are typically the largest and most readily accessible fat pads and, for these and other reasons, they are the most frequently used in the literature (19–21). However, humans do not harbor a fat depot analogous to these fat pads, which has led to the suggestion that these pads should be considered “peri-visceral” rather than true visceral fat pads. Another difference between the two species is the ambiguity when referencing the omental depot in rodents. Though it is clearly defined and developed in humans, it is less so in rodents, leading some investigators to not reference the omental depot at all (13). However, based on the literature, it seems that the omental depot is present in the mouse, albeit in small quantities, and is similarly connected to the stomach, as it is in humans (22). Thus, although adipose tissue is a multi-depot organ in both humans and rodents, there are anatomical differences that should be taken into consideration. FAT PAD AND DEPOT DISTRIBUTION IN HEALTH AND DISEASE In humans, increased VAT is associated with an increased risk for insulin resistance and dyslipidemias (23),

Read the complete text